Stock overview
Dianthus Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
DIANTHUS THERAPEUTICS INC (DNTH) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $83.98
- · DNTH
- Tracked holders
- 3 funds
- Latest available 13F per fund
DNTH · USD
Price
Close · Nov 18, 2026
- Range low
- $36.20
- Range high
- $115.96
- Observations
- 252
- Session date
- Nov 18, 2026
Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | — | $75,033,040 | 0.36% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | +150% 26'Q3 | $8,219,732 | 0.01% |
| Polen Capital Management position history Q3 2026 · filed Nov 13, 2026 · SEC filing | +167% 26'Q3 | $2,194,822 | 0.02% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market